Theoretical study of 5-aminolevulinic acid (5ALA) and some pharmaceutically important derivatives

Chemical Physics Letters

Volumn 434, Issue 1-3, 2007, Pages 101-106

  Erdtman, Edvin ^a   Eriksson, Leif A ^a  

^a ÖREBRO UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CHROMOPHORES; DIAGNOSIS; ESTERS; PHOTODYNAMIC THERAPY; PROBABILITY DENSITY FUNCTION; SKIN; TUMORS;

5-AMINOLEVULINIC ACID (5ALA); ALKYL ESTER DERIVATIVES; HEME CHROMOPHORE; MITOCHONDRIA; PROTOPORPHYRIN;

DRUG PRODUCTS;

EID: 33846018089     PISSN: 00092614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cplett.2006.11.084     Document Type: Article

References (29)

1. In: Patrice T. (Ed). Photodynamic Therapy (2004), RSC Publishing and references therein
2. In: Baumgartner R., Pottier R., Krammer B., and Stepp H. (Eds). Photodynamic Therapy with ALA (2006), RSC Publishing and references therein
3. Peng Q., Warloe T., Berg K., Moan J., Kongshaug M., Giercksky K.-E., and Nesland J.M. Cancer 79 (1997) 2282
4. Gaullier J.M., Berg K., Peng Q., Anholt H., Selbo P.K., Ma L.W., and Moan J. Cancer Res. 57 (1997) 1481
5. Lange N., et al. Br. J. Cancer 80 (1999) 185
6. Stephens P.J., Devlin F.J., Chabalowski C.F., and Frisch M.J. J. Phys. Chem. 98 (1994) 11623
7. Becke A.D. J. Chem. Phys. 98 (1993) 5648
8. Lee C.T., Yang W.T., and Parr R.G. Phys. Rev. B 37 (1988) 785
9. Frisch M.J., et al. Gaussian 03, Revision B.02/C.02. (2003), Gaussian, Inc., Pittsburgh, PA
10. Cancès E., and Mennucci B. J. Chem. Phys. 114 (2001) 4744
11. Cancès E., Mennucci B., and Tomasi J. J. Chem. Phys. 107 (1997) 3032
12. Pepe C., Rochut S., Paumard J.P., and Tabet J.C. Rap. Commun. Mass Spec. 18 (2004) 307
13. Llano J., and Eriksson L.A. J. Chem. Phys. 117 (2002) 10193
14. Fitzgerald G., and Andzelm J. J. Phys. Chem. 95 (1991) 10531
15. Topol I.A., Burt S.K., Toscano M., and Russo N. J. Mol. Struct. (THEOCHEM) 430 (1998) 41
16. Lias S.G., Liebman J.F., and Levin R.D. J. Phys. Chem. Ref. Data 13 (1984) 695
17. Afonso C., Modeste F., Breton P., Fournier F., and Tabet J.C. Eur. J. Mass Spec. 6 (2000) 443
18. Li X., and Harrison A.G. Org. Mass Spec. 28 (1993) 366
19. Meot-Ner M., Hunter E.P., and Field F.H. J. Am. Chem. Soc. 101 (1979) 686
20. Hunter E.P.L., and Lias S.G. J. Phys. Chem. Ref. Data 27 (1998) 413
21. Locke M.J., and McIver Jr. R.T. J. Am. Chem. Soc. 105 (1983) 4226
22. Noguera M., Rodriguez-Santiago L., Sodupe M., and Bertran J. J. Mol. Struct. (THEOCHEM) 537 (2001) 307
23. Cassady C.J., Carr S.R., Zhang K., and Chungphillips A. J. Org. Chem. 60 (1995) 1704
24. Graul S.T., Schnute M.E., and Squires R.R. Int. J. Mass Spec. Ion Proc. 96 (1990) 181
25. Schmidbauer J., Mitjes F., Schmeller N., Donat R., Susani M., Marberger M., and Hexvix PCB301/01 Study Group. J. Urol. 171 (2004) 135
26. Gardlo K., and Ruzicka T. Curr. Opin. Invest. Drugs 3 (2002) 1672
27. Perotti C., Fukuda H., Di Venosa G., MacRobert A., Batlle A., and Casas A. Br. J. Cancer 90 (2004) 1660
28. Rud R., Gederaas O., Hogset A., and Berg K. Photochem. Photobiol. 73 (2000) 164
29. Rodriguez S.L., Batlle A., Di Venosa G., Bata S., Dobbin P., MacRobert A.J., and Casas A. Br. J. Pharmacol. 147 (2006) 825 and references therein